It should come as no surprise to most people that cancer research and drug development is expensive. But that the plan of his research institute would receive 662 million euros, that was what Alain Kummer, one of the directors of the Oncode Institute in Utrecht, was “awake” in the beginning. “That is a bizarre amount. But,” he puts into perspective, “in the world of cancer research and drug development it is actually nothing. That may sound silly, but it is the reality.”
rnl-general-02
This is how Utrecht researchers use mini-organs in the fight against cancer
